Asthma Ctrl for Asthma

This trial tests a mobile health app designed to help teenagers with asthma adhere to their daily inhaler routine. Researchers aim to determine if this app improves asthma management compared to a standard asthma management app. They are also comparing two versions of the app, Asthma Ctrl and Asthma Ctrl+, to identify which one better improves lung function and reduces the need for medical visits. Teens with moderate to severe asthma who use inhaler medication daily may be well-suited for this study. As an unphased trial, this study provides a unique opportunity for participants to contribute to innovative asthma management solutions.

The trial does not specify if you need to stop taking your current medications. However, since it focuses on adherence to daily inhaled corticosteroids, you will likely continue your current asthma medications.

Research shows that the Asthma Ctrl and Asthma Ctrl+ programs help people manage asthma by improving medication adherence. These programs use proven methods to control asthma. Studies have found that similar approaches can reduce symptoms and improve medication regularity in people with asthma.

Regarding safety, no specific side effects have been reported for these programs, as they focus on adherence to existing asthma medication plans. This trial does not test a new drug; it evaluates the effectiveness of these strategies rather than seeking side effects. As a result, the programs are expected to be safe since they do not involve new medications.

Researchers are excited about the Asthma Ctrl and Asthma Ctrl+ interventions because they offer a fresh, tech-driven approach to managing asthma. Unlike traditional treatments that rely primarily on medications like inhaled corticosteroids and bronchodilators, these interventions leverage a mobile application to enhance patient education and provide automated reminders, potentially improving self-management and adherence. Asthma Ctrl+ likely includes additional features or support beyond the basic application, offering even more comprehensive management. This focus on digital health tools could empower patients to take control of their asthma more effectively and may lead to better outcomes in managing their condition.

This trial will compare the effectiveness of different asthma management interventions. Participants may receive the Asthma Ctrl intervention, which studies have shown helps people manage their asthma better by encouraging adherence to treatment plans. Another group will receive the Asthma Ctrl+ intervention, which research indicates improves asthma control and quality of life while reducing the need for healthcare services. Additionally, a control group will have access to an asthma management application that provides education and automated reminders. These approaches aim to help patients manage their asthma more effectively, leading to fewer flare-ups and better overall health. Evidence supports that both Asthma Ctrl and Asthma Ctrl+ promote regular inhaler use, aiding in asthma management.²⁴⁶⁷⁸